Skip to content

Justin Smith: A New Era for Alzheimer’s Treatment

October 29, 2026 · 31 min

Show notes

Senior European Biopharmaceuticals Analyst Justin Smith joins host Diana Wood to explore the long-term investment opportunity in Alzheimer’s disease, drawing parallels with the evolution of the multiple sclerosis drug market. Justin discusses how advances in diagnostics, including new blood tests, could drive earlier diagnosis and greater treatment uptake, alongside the next generation of therapies. He also examines Roche’s potential competitive advantage through its brain shuttle technology, the promise of gamma-secretase modulators, and the possibility of combination treatments.

Hosted on Acast. See acast.com/privacy for more information.

All episodes of In the Know

Settings

Display

Language

Decides which stations you see first on the home page.

History

Recently played stations and episodes and your latest searches are only stored in this browser.

Notifications

A short notice when a podcast you follow has a new episode. Turn off single podcasts with the bell on their page.

Account

Save favorites – in the app and on the website.

Keyboard shortcuts

/
Open search
Space
Play or pause
← →
In the player: back 15 s, forward 30 s (episodes) · in a row: next tile
↑ ↓
In a row: target within the tile
Home / End
In a row: first or last tile
Esc
Close window or menu
?
This overview
Now playing

Go to station page

Play next

    Add episodes with “Play next” – they play after the current episode.